C
2.27
0.11 (5.09%)
| Previous Close | 2.16 |
| Open | 2.20 |
| Volume | 188,500 |
| Avg. Volume (3M) | 2,518,815 |
| Market Cap | 2,894,976,512 |
| Price / Sales | 5.73 |
| Price / Book | 5.94 |
| 52 Weeks Range | |
| Earnings Date | 25 Mar 2025 - 31 Mar 2025 |
| Profit Margin | -31.17% |
| Operating Margin (TTM) | -1.44% |
| Diluted EPS (TTM) | -0.110 |
| Quarterly Revenue Growth (YOY) | -2.80% |
| Total Debt/Equity (MRQ) | 71.56% |
| Current Ratio (MRQ) | 1.71 |
| Operating Cash Flow (TTM) | -435.15 M |
| Levered Free Cash Flow (TTM) | -334.73 M |
| Return on Assets (TTM) | -13.91% |
| Return on Equity (TTM) | -26.57% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (HK) | Mixed | Mixed |
| Biotechnology (Global) | Mixed | Mixed | |
| Stock | CSTONE PHARMA-B | - | - |
AIStockmoo Score
-1.4
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -4.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -1.0 |
| Average | -1.38 |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| CSTONE PHARMA-B | 3 B | - | - | 5.94 |
| LEPU BIO-B | 5 B | - | - | 4.75 |
| FRONTAGE | 3 B | - | 83.00 | 1.29 |
| ALPHAMAB-B | 3 B | - | - | 1.88 |
| ABBISKO-B | 3 B | - | - | 1.21 |
| GENOR-B | 930 M | - | - | 0.800 |
|
CStone Pharmaceuticals is engaged in the development and commercialization of tumor immunotherapy and molecular-targeted drugs. It has been operating in one reportable segment, the research and development of complex biopharmaceutical products. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Core |
| % Held by Insiders | 44.52% |
| % Held by Institutions | 5.72% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |